Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Should optical coherence tomography be used to manage patients with multiple sclerosis?
Temporal Hierarchical Adaptive Texture CRF for Automatic Detection of Gadolinium-Enhancing Multiple Sclerosis Lesions in Brain MRI.
Fast facts: multiple sclerosis.
Coping Among Individuals With Multiple Sclerosis: Evaluating a Goodness-of-Fit Model.
Inhibition of Myeloperoxidase at the Peak of Experimental Autoimmune Encephalomyelitis Restores Blood-Brain-Barrier Integrity and Ameliorates Disease Severity.
Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica.
Cytokines gene expression in newly diagnosed multiple sclerosis patients.
Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance.
Targeting ion channels for the treatment of autoimmune neuroinflammation.
Statistical colocalization of genetic risk variants for related autoimmune diseases in the context of common controls.
The role of cerebellar abnormalities in neuromyelitis optica - a comparison with multiple sclerosis and healthy controls.
Fatigue and its association with sleep disorders, depressive symptoms and anxiety in patients with multiple sclerosis.
Imaging and diagnostic criteria for Multiple Sclerosis: Are we there yet?
Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis?
Orbital and optic nerve complications of inflammatory bowel disease.
Treatment of Neuromyelitis Optica: Review and Recommendations.
Gait kinematics of people with Multiple Sclerosis and the acute application of Functional Electrical Stimulation.
Fatigue in Multiple Sclerosis: Assessing Pontine Involvement Using Proton MR Spectroscopic Imaging.
Cerebrospinal fluid oligoclonal IgG bands in multiple sclerosis: what does it mean?
JC virus detection and JC virus-specific immunity in natalizumab-treated Multiple Sclerosis patients.
T cell responses after hematopoietic stem cell transplantation for aggressive relapsing-remitting multiple sclerosis.
Gilenya Safety Update
Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MS.
Fingolimod (Gilenya) may improve the chances of conception in women with multiple sclerosis (MS) associated with secondary infertlity.
Meningoencephalitis as an initial manifestation of neuromyelitis optica spectrum disorder.
Pages
« first
‹ previous
…
362
363
364
365
366
367
368
369
370
…
next ›
last »